SCHEMBL726951

SCHEMBL726951

CCCCCCCCCC(O)=CC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 4/20 0.56
PTPN1 P18031 3/20 0.56
FABP4 P15090 3/20 0.56
ALDH1A1 P00352 2/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
PDE4A P27815 1/20 0.56
KMT2A Q03164 1/20 0.56
PDE3A Q14432 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3345559 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8088535 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5000537 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL15516842 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8075409 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL726950 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL25356914 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3345555 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3349403 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3349408 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076887-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS PROCTER & GAMBLE (US) 2026-03-19 US claimed
US-20260000078-A1 ANTI-MICROBIAL SYSTEM PROCTER & GAMBLE (US) 2026-01-01 US claimed
US-20260000596-A1 SEMI-SYNTHETIC RHAMNOLIPIDS PROCTER & GAMBLE (US) 2026-01-01 US claimed
US-20250268806-A1 PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT THE PROCTER & GAMBLE COMPANY 2025-08-28 US claimed
US-20250268805-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS THE PROCTER & GAMBLE COMPANY 2025-08-28 US claimed
US-20240182632-A1 POLYMER COMPRISING LONG CHAIN HYDROXY ACIDS EVONIK OPERATIONS GMBH (DE) 2024-06-06 US claimed
EP-4326799-A1 POLYMER COMPRISING LONG CHAIN HYDROXY ACIDS Evonik Operations GmbH (DE) 2024-02-28 EP claimed
CN-117279976-A Polymers comprising long chain hydroxy acids 赢创运营有限公司 2023-12-22 CN claimed
WO-2022223346-A1 POLYMER COMPRISING LONG CHAIN HYDROXY ACIDS EVONIK OPERATIONS GMBH (DE) 2022-10-27 WO claimed
EP-3320088-A1 EXTRACELLULAR PRODUCTION OF DESIGNER HYDROXYALKANOYLOXY ALKANOIC ACIDS WITH RECOMBINANT BACTERIA Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) (DE) 2018-05-16 EP claimed
EP-1935945-A1 PHA Blends Metabolix, Inc. (US) 2008-06-25 EP claimed
JP-2007517126-A 2007-06-28 JP claimed
EP-1704180-A1 NUCLEATING AGENTS Metabolix, Inc. (US) 2006-09-27 EP claimed
EP-1603987-A1 PHA BLENDS Metabolix, Inc. (US) 2005-12-14 EP claimed
US-20050209377-A1 Thermoplastic polyester, polyolefin or aromatic polymer and a nucleant of a core of pyridine, pyrimidine, pyrazine, pyridazine, triazine, imidazole, cyanuric acid or a metal heterocyclic complex; nucleants improve chrystallization rate of the polymers CJ CHEILJEDANG CORPORATION (KR) 2005-09-22 US claimed
WO-2005066256-A1 NUCLEATING AGENTS METABOLIX, INC. (US) 2005-07-21 WO claimed
US-20040220355-A1 PHA blends CJ CHEILJEDANG CORPORATION (KR) 2004-11-04 US claimed
WO-2004076582-A1 PHA BLENDS METABOLIX INC. (US) 2004-09-10 WO claimed
EP-1044278-A1 BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES MONSANTO COMPANY (US) 2000-10-18 EP claimed
WO-1999035278-A1 BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES MONSANTO COMPANY (US) 1999-07-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250268805-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS SMURF1, CUTA, SMURF2 GPR84 522/4885PPARG 1306/4885PPARD 687/4885
US-20260000596-A1 SEMI-SYNTHETIC RHAMNOLIPIDS LPAR3, LPAR1, LPAR2 GPR84 442/4885PPARG 2145/4885PPARD 1970/4885
US-20260000078-A1 ANTI-MICROBIAL SYSTEM MGLL, LIPA, LIPC GPR84 3670/4885PPARG 2517/4885PPARD 1447/4885
US-20260076887-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS CUTA, PHOSPHO1, MGLL GPR84 1057/4885PPARG 2937/4885PPARD 1256/4885
US-20250268806-A1 PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT CUTA, LRAT, MGLL GPR84 963/4885PPARG 1481/4885PPARD 1510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.